Zum Hauptinhalt springen
Hochschulbibliothek der Hochschule Düsseldorf

Suchergebnisse

Katalog

Mehr
18.544 Treffer

Suchmaske

Suchtipp für den Bereich Mehr: Wörter werden automatisch mit UND verknüpft. Eine ODER-Verknüpfung erreicht man mit dem Zeichen "|", eine NICHT-Verknüpfung mit einem "-" (Minus) vor einem Wort. Anführungszeichen ermöglichen eine Phrasensuche.
Beispiele: (burg | schloss) -mittelalter, "berufliche bildung"

Das folgende Suchfeld wird hier nicht unterstützt: "Signatur".

Suchergebnisse einschränken oder erweitern

Aktive Suchfilter

Erscheinungszeitraum

Mehr Treffer

Weniger Treffer

Art der Quelle

Thema

Verlag

Publikation

Sprache

Geographischer Bezug

Inhaltsanbieter

18.544 Treffer

Sortierung: 
  1. Detailansicht für Treffer 1 öffnen
    University of Gothenburg Researchers Further Understanding of Neuroblastomas (Comparison of 177Lu-octreotate and 177Lu-octreotide for treatment in human neuroblastoma-bearing mice).
    In: Drug Week, 2024-06-13, S. 1929-1929
    serialPeriodical
    Wie komme ich dran?
  2. Detailansicht für Treffer 2 öffnen
    Researchers at Radiation Medical Center Report New Data on Carcinomas (Clinical Internal Dosimetry and Biodistribution of <superscript>177</superscript>lu-dota-trastuzumab In Her2-positive Metastatic and Locally Advanced Breast Carcinoma).
    In: Immunotherapy Weekly, 2024-04-30, S. 1090-1090
    serialPeriodical
    Wie komme ich dran?
  3. Detailansicht für Treffer 3 öffnen
    Studies in the Area of Hormone Replacement Therapy Reported from Guangxi Normal University (Design, Synthesis And In Vitro Antitumor Activity of 17fi-estradiol-amino Acid Derivatives).
    In: Drug Week, 2024-02-16, S. 1154-1154
    serialPeriodical
    Wie komme ich dran?
  4. Detailansicht für Treffer 4 öffnen
    Researchers from University of California San Francisco (UCSF) Report Details of New Studies and Findings in the Area of Prostate Cancer (Single-dose 177lu-psma-617 Followed By Maintenance Pembrolizumab In Patients With Metastatic Castration-...).
    In: Immunotherapy Weekly, 2024, S. 1110-1110
    serialPeriodical
    Wie komme ich dran?
  5. Detailansicht für Treffer 5 öffnen
    New Theranostics Research from National Center for Scientific Research "Demokritos" Discussed (<superscript>177</superscript>Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer).
    In: Women's Health Weekly, 2024-03-26, S. 691-691
    serialPeriodical
    Wie komme ich dran?
  6. Detailansicht für Treffer 6 öffnen
    Study Data from University of Zurich Update Knowledge of Antineoplastic Monoclonal Antibodies (Radiolabelled <superscript>177</superscript>lu-bispidine-trastuzumab for Targeting Human Epidermal Growth Factor Receptor 2 Positive Cancers).
    In: Immunotherapy Weekly, 2024-02-20, S. 1005-1005
    serialPeriodical
    Wie komme ich dran?
  7. Detailansicht für Treffer 7 öffnen
    Machine-Learning Identifies a Strategy for Differentiation Therapy in Solid Tumors (Updated January 17, 2024).
    In: Drug Week, 2024-01-30, S. 397-397
    serialPeriodical
    Wie komme ich dran?
  8. Detailansicht für Treffer 8 öffnen
    New Findings in Xenografts Described from Peking University Cancer Hospital and Institute ([<superscript>177</superscript>lu]Lu-labeled Anti-claudin-18.2 Antibody Demonstrated Radioimmunotherapy Potential In Gastric Cancer Mouse Xenograft Models).
    In: Immunotherapy Weekly, 2024-01-12, S. 401-401
    serialPeriodical
    Wie komme ich dran?
  9. Detailansicht für Treffer 9 öffnen
    Researcher at University of Wisconsin School of Medicine and Public Health Releases New Data on Head and Neck Cancer (Stress Keratin 17 Is a Predictive Biomarker Inversely Associated with Response to Immune Check-Point Blockade in Head and Neck...).
    In: Immunotherapy Weekly, 2023-10-24, S. 829-829
    serialPeriodical
    Wie komme ich dran?
  10. Detailansicht für Treffer 10 öffnen
    Phase 2 Study to Evaluate the Efficacy of Regorafenib in Specific GIST Mutation Subsets (KIT Exon 17, 18, or 14 Mutation and SDHB Deficient GIST) in the Post-imatinib Second-line Setting.
    In: Medical Letter on the CDC & FDA, 2023-11-03, S. 876-876
    serialPeriodical
    Wie komme ich dran?
  11. Detailansicht für Treffer 11 öffnen
    Findings on Disease Progression Reported by Investigators at Dartmouth College Geisel School of Medicine (Alternating 17b-estradiol and Aromatase Inhibitor Therapies Is Efficacious In Postmenopausal Women With Advanced Endocrine-resistant Er...).
    In: Women's Health Weekly, 2023-09-12, S. 409-409
    serialPeriodical
    Wie komme ich dran?
  12. Detailansicht für Treffer 12 öffnen
    CRISPR/Cas9 screen identifies KRAS-induced COX-2 as a driver of immunotherapy resistance in lung cancer (Updated August 17, 2023).
    In: Immunotherapy Weekly, 2023-09-05, S. 186-186
    serialPeriodical
    Wie komme ich dran?
  13. Detailansicht für Treffer 13 öffnen
    New Pancreatic Cancer Data Have Been Reported by Researchers at University of South Australia (In vitro characterisation of [177Lu]Lu-DOTA-C595 as a novel radioimmunotherapy for MUC1-CE positive pancreatic cancer).
    In: Immunotherapy Weekly, 2023-09-05, S. 716-716
    serialPeriodical
    Wie komme ich dran?
  14. Detailansicht für Treffer 14 öffnen
    New Neuroendocrine Cancer Study Findings Have Been Reported by Investigators at Postgraduate Institute of Medical Education and Research (Sunitinib In Tandem With <superscript>177</superscript>lu-dotatate Therapy In Advanced Pancreatic Neuroendocrine Tumor a.
    In: Gastroenterology Week, 2024-02-13, S. 1331-1331
    serialPeriodical
    Wie komme ich dran?
  15. Detailansicht für Treffer 15 öffnen
    Studies from Cedars Sinai Medical Center in the Area of Prostate Cancer Described (The 17-gene Genomic Prostate Score Test Is Prognostic for Outcomes After Primary External Beam Radiation Therapy In Men With Clinically Localized Prostate Cancer).
    In: Drug Week, 2023-08-04, S. 1008-1008
    serialPeriodical
    Wie komme ich dran?
  16. Detailansicht für Treffer 16 öffnen
    Research from Texas Tech University Has Provided New Study Findings on Glioblastomas (Abstract 170: Glioblastoma patient-derived organoids as a model for discovering novel markers of therapy resistance in the context of tumor microenvironment:...).
    In: Immunotherapy Weekly, 2023-06-27, S. 783-783
    serialPeriodical
    Wie komme ich dran?
  17. Detailansicht für Treffer 17 öffnen
    Reports from Nanchang University Provide New Insights into Breast Cancer (Fulvestrant May Falsely Increase 17 Beta-estradiol Levels In Immunoassays: a Case Report of a 57-year-old Postmenopausal Patient With Recurrent Estrogen Receptor-positive...).
    In: Women's Health Weekly, 2023-05-02, S. 637-637
    serialPeriodical
    Wie komme ich dran?
  18. Detailansicht für Treffer 18 öffnen
    Reports from Mansoura University Add New Data to Findings in Liver Cancer (Nlrp3 Inflammasome Activation By 17 Beta-estradiol Is a Potential Therapeutic Target In Hepatocellular Carcinoma Treatment).
    In: Cancer Weekly, 2023-03-21, S. 778-778
    serialPeriodical
    Wie komme ich dran?
  19. Detailansicht für Treffer 19 öffnen
    A Phase I Dose Escalation-Expansion Trial of Sunitinib Malate Plus Lutetium Lu 177 Dotatate (Lutathera) in Somatostatin Receptor Positive Pancreatic Neuroendocrine Tumors.
    In: Hepatitis Weekly, 2023-01-30, S. 19-19
    serialPeriodical
    Wie komme ich dran?
  20. Detailansicht für Treffer 20 öffnen
    New Osteosarcomas Research from University of Catania Described (Abstract 1700: Clonal emergence of resistance to methotrexate in osteosarcoma barcoded PDX cells).
    In: Cancer Weekly, 2023-06-27, S. 557-557
    serialPeriodical
    Wie komme ich dran?

Weitere Bibliothekskataloge

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -